Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS)
Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The initial hypothesis is that branched-chain aminoacids (BCAA) administration could be
beneficial to patients suffering from sleep apnea syndrome (SAS), the aim of the present work
is to verify this hypothesis.
The literature data demonstrate that a BCAA complementation improves the physical
performances, protects lean mass and increases VO2 max during training.
We demonstrated earlier that this complementation can cure at less partly the hypoxemia of
chronic obstructive pulmonary patients by a stimulation of respiratory centres.